Description

Technical Parameters

Introduction

peptides

product-1400-1400

Products Description

### Systematic introduction of FOXO4 peptides

#### 1. **Introduction**

FOXO (Forkhead box O) protein family is a key transcription factor that regulates processes such as cell cycle, anti-oxidative stress, autophagy and apoptosis. As an important member, FOXO4 participates in maintaining cell homeostasis, especially highly expressed in aging cells. FOXO4 peptides are bioactive molecules designed by mimicking or interfering with FOXO4 function, and have attracted much attention in the field of anti-aging and disease treatment in recent years.

#### 2. **Structural classification**

FOXO4 peptides can be divided into the following categories according to design strategies and modification types:

- **Naturally derived peptides**

Short peptides based on the natural domain of FOXO4 protein, such as fragments that bind to p53. For example, FOXO4-DRI (interfering peptide) consists of 10-20 amino acids, mimics the interaction region of FOXO4, blocks its binding to p53, and induces apoptosis of aging cells.

- **Synthetic modified peptides**

- **PEGylated peptides**: Polyethylene glycol modification enhances water solubility and half-life, and reduces immunogenicity.

- **Lipidated peptides**: Adding fatty acid chains enhances cell membrane permeability, suitable for targeted delivery.

- **Fluorescently labeled peptides**: Such as FITC labeling, used to track intracellular distribution.

#### 3. **Functional classification**

The functional diversity of FOXO4 peptides makes it potential in multiple fields:

- **Anti-aging and elimination of senescent cells**

FOXO4-DRI selectively eliminates senescent cells and improves aging-related phenotypes (such as liver fibrosis and osteoarthritis) by interfering with FOXO4-p53 interaction. Animal experiments show that it can restore tissue function and prolong healthy lifespan.

- **Anti-cancer treatment**

Some FOXO4 peptides can induce apoptosis of cancer cells or enhance chemotherapy sensitivity. For example, peptides targeting FOXO4 binding to β-catenin can inhibit tumor growth.

- **Metabolic regulation**

By activating the antioxidant pathway downstream of FOXO4 (such as SOD2), it improves insulin resistance and oxidative stress and has potential application in the treatment of diabetes.

#### 4. **Physical and chemical properties**

- **Molecular weight**: Usually between 1-5 kDa. For example, FOXO4-DRI (10-15 amino acids) is about 1.2-1.8 kDa.

- **Solubility**: Hydrophilic peptides are easily soluble in water or buffer; hydrophobic modified peptides require DMSO to assist in dissolution.

- **Stability**: The lyophilized state is stable at -20°C; the liquid state is easily degraded and needs to be protected from light and frozen. PEGylation can enhance plasma stability.

#### 5. **Color and morphology**

- **Basic peptide**: White or off-white lyophilized powder, no significant hygroscopicity.

- **Modified peptide**: PEGylation may be slightly milky white; fluorescent labeled peptides (such as Cy5 labeled) are blue or red powder.

- **Formulation**: The solution is transparent or slightly turbid, depending on the concentration and solvent.

#### 6. **Core advantages**

- **High specificity**: Precisely target FOXO4-related pathways to reduce off-target effects.

- **Low toxicity**: Animal experiments show good tolerance and no significant organ damage.

- **Modifference**: Optimize pharmacokinetics through chemical modification (such as extending the half-life to several hours).

- **Penetration**: Lipidation or cell-penetrating peptide (CPP) fusion design enhances cellular uptake efficiency.

#### 7. **Application areas**

- **Anti-aging therapy**: Local injection or systemic administration to reduce the accumulation of senescent cells.

- **Adjuvant tumor therapy**: Combined with chemotherapy to enhance efficacy and reduce drug resistance.

- **Metabolic diseases**: Oral or subcutaneous administration regulates glucose and lipid metabolism.

- **Research tools**: Fluorescently labeled peptides are used to dynamically observe the intracellular behavior of FOXO4.

#### 8. **Research progress and challenges**

- **Preclinical results**: In mouse models, FOXO4-DRI reduced senescent cells by 80% and significantly improved renal function.

- **Challenges**:

- **Delivery efficiency**: A more efficient targeted delivery system needs to be developed.

- **Long-term safety**: The impact of repeated administration on the immune system needs to be evaluated.

- **Scale-up production**: The synthesis cost of complex modified peptides is high.

#### 9. **Future prospects**

The potential of FOXO4 peptides lies in their versatility and engineering properties. Future directions include:

- **Peptide-drug conjugates**: Combining antibodies or nanoparticles to enhance targeting.

- **Oral formulation development**: Enhance gastrointestinal stability through structural optimization.

- **Combination therapy**: Synergistic with senolytics or immunotherapy.

#### 10. **Conclusion**

FOXO4 peptides have become an emerging strategy for anti-aging and disease treatment due to their structural diversity and functional specificity. With the advancement of delivery technology and modification methods, its clinical application prospects are broad and it is expected to provide breakthrough solutions for age-related diseases.